Advertisement
BDX vs CNMD
Which Stock Would AI Choose? Becton, Dickinson and Company (BDX) vs. CONMED Corporation (CNMD) Stock Comparison
Key Takeaways
- Becton, Dickinson and Company (BDX) operates as a large-cap diversified medical technology firm with broad exposure across diagnostics, medication management, and surgical products, providing relative stability compared to smaller peers.
- CONMED Corporation (CNMD) focuses on specialized surgical equipment and consumables, delivering recent organic sales growth despite flat reported revenue in its latest quarter.
- Recent market activity shows BDX exhibiting modest price resilience amid broader healthcare sector pressures, while CNMD has shown volatility tied to earnings outcomes and growth signals.
- Both companies face sector-wide headwinds including regulatory scrutiny and reimbursement dynamics, yet differ in scale, with BDX benefiting from global diversification and CNMD emphasizing targeted procedure areas.
- Market sentiment reflects cautious positioning for both, with BDX viewed for defensive qualities and CNMD for potential rebound in procedural volumes.
- Relative performance highlights trade-offs between established scale (BDX) and higher-beta growth exposure (CNMD) in the current environment.
Introduction
This comparison examines Becton, Dickinson and Company (BDX) and CONMED Corporation (CNMD), two healthcare equipment companies operating in overlapping yet distinct segments of the medical technology space. Investors and traders seeking to understand relative positioning within the sector, including differences in business scale, growth profiles, and recent momentum, may find this analysis relevant. The discussion draws on observable market data and company developments to highlight contrasts that could inform portfolio allocation decisions in a neutral market context.
BDX Overview and Recent Performance
Becton, Dickinson and Company (BDX) develops, manufactures, and sells a wide range of medical devices and diagnostic solutions used in hospitals, laboratories, and clinics worldwide. Its portfolio spans medication and supply management, biosciences, and interventional procedures. In recent weeks, the stock has displayed measured price behavior amid mixed sector sentiment, with influences including ongoing integration of technology advancements and international expansion initiatives. Broader market activity has contributed to a relatively contained performance range, supported by the company’s diversified revenue base and established market presence.
CNMD Overview and Recent Performance
CONMED Corporation (CNMD) specializes in surgical devices and equipment primarily for orthopedic, general surgery, and other procedural applications. The company serves healthcare facilities with tools and consumables that support minimally invasive and open procedures. Recent market activity has reflected responses to quarterly results showing flat reported sales alongside organic constant-currency growth, alongside adjustments to full-year guidance. Sentiment has been shaped by these operational updates and broader industry demand patterns, resulting in noticeable price fluctuations over recent weeks.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available across the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and performance metrics tailored to current market conditions. Only those demonstrating the strongest alignment with prevailing trends and risk-adjusted outcomes earn placement in the trending section. Available bots span a wide range of statistics, including win rates, profit factors, and drawdown profiles that differ by style and ticker focus. This resource provides traders with data-driven options for automated strategies. Explore the full selection on the Trending AI Robots page.
Head-to-Head Comparison
In business model terms, Becton, Dickinson and Company (BDX) maintains a larger, more diversified operation across multiple medical technology categories, contrasting with CONMED Corporation (CNMD)’s narrower focus on surgical instrumentation and consumables. Growth drivers differ accordingly: BDX benefits from scale and recurring revenue streams in diagnostics and supply management, while CNMD emphasizes procedural volume recovery and organic expansion in targeted specialties. Recent momentum shows BDX with comparatively steadier price action versus CNMD’s sharper reactions to earnings data. Risk factors include BDX’s exposure to global supply chains and regulatory environments, set against CNMD’s higher sensitivity to elective procedure trends and smaller market capitalization. Sector exposure remains healthcare equipment for both, though BDX offers broader geographic reach. Market sentiment positions BDX as a more defensive holding amid volatility, while CNMD presents a higher-beta profile with potential for amplified moves tied to operational execution.
Tickeron AI Verdict
Based on observable factors such as trend consistency, scale-driven stability, and positioning within a defensive sector segment, Tickeron’s AI would currently assign a higher probabilistic preference to Becton, Dickinson and Company (BDX) over CONMED Corporation (CNMD). The larger company’s diversified operations and measured recent performance provide a more consistent profile in the current environment, though outcomes remain subject to ongoing market dynamics and company-specific catalysts.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and CNMD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 2 FA rating(s) are green whileCNMD’s FA Score has 2 green FA rating(s).
- BDX’s FA Score: 2 green, 3 red.
- CNMD’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 5 TA indicator(s) are bullish while CNMD’s TA Score has 4 bullish TA indicator(s).
- BDX’s TA Score: 5 bullish, 4 bearish.
- CNMD’s TA Score: 4 bullish, 5 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а +3.70% price change this week, while CNMD (@Medical/Nursing Services) price change was +2.63% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.26%. For the same industry, the average monthly price growth was +8.63%, and the average quarterly price growth was +6.97%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.55%. For the same industry, the average monthly price growth was +1.91%, and the average quarterly price growth was -4.26%.
Reported Earning Dates
BDX is expected to report earnings on Nov 05, 2026.
CNMD is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.26% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+1.55% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BDX | CNMD | BDX / CNMD | |
| Capitalization | 50B | 1.51B | 3,311% |
| EBITDA | 4.97B | 188M | 2,643% |
| Gain YTD | 21.791 | 24.163 | 90% |
| P/E Ratio | 31.73 | 27.25 | 116% |
| Revenue | 22.2B | 1.37B | 1,618% |
| Total Cash | N/A | 37.3M | - |
| Total Debt | 17.3B | 834M | 2,074% |
BDX | CNMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 33 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 89 | 100 | |
SMR RATING 1..100 | 86 | 83 | |
PRICE GROWTH RATING 1..100 | 14 | 41 | |
P/E GROWTH RATING 1..100 | 62 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDX's Valuation (7) in the Medical Specialties industry is in the same range as CNMD (11). This means that BDX’s stock grew similarly to CNMD’s over the last 12 months.
BDX's Profit vs Risk Rating (89) in the Medical Specialties industry is in the same range as CNMD (100). This means that BDX’s stock grew similarly to CNMD’s over the last 12 months.
CNMD's SMR Rating (83) in the Medical Specialties industry is in the same range as BDX (86). This means that CNMD’s stock grew similarly to BDX’s over the last 12 months.
BDX's Price Growth Rating (14) in the Medical Specialties industry is in the same range as CNMD (41). This means that BDX’s stock grew similarly to CNMD’s over the last 12 months.
CNMD's P/E Growth Rating (10) in the Medical Specialties industry is somewhat better than the same rating for BDX (62). This means that CNMD’s stock grew somewhat faster than BDX’s over the last 12 months.
| BDX | CNMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | 1 day ago 89% |
| Stochastic ODDS (%) | 1 day ago 46% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 50% | N/A |
| MACD ODDS (%) | 1 day ago 51% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 47% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 50% | 1 day ago 64% |
| Advances ODDS (%) | 4 days ago 44% | 1 day ago 69% |
| Declines ODDS (%) | 24 days ago 43% | 11 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 50% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 60% |
Advertisement
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | +0.79% | ||
| COO - BDX | 54% Loosely correlated | -0.56% | ||
| BAX - BDX | 51% Loosely correlated | -1.18% | ||
| TMO - BDX | 50% Loosely correlated | -1.28% | ||
| CNMD - BDX | 48% Loosely correlated | +1.18% | ||
| SOLV - BDX | 47% Loosely correlated | +2.46% | ||
More | ||||